Drug Shortage Report for BRAVELLE

Last updated on 2019-01-10 History
Report ID 802
Drug Identification Number 02268140
Brand name BRAVELLE
Common or Proper name BRAVELLE
Company Name FERRING INC
Active Ingredient(s) Urofollitropin for injection
Strength(s) 75 IU's per vial
Dosage form(s) Powder for Injection
Route of administration Subcutaneous
Packaging size 5 vials
ATC code G03GA
ATC description GONADOTROPHINS AND OTHER OVULATION STIMULANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2015-09-09
Actual start date 2015-10-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-01-10
Company comments
Health Canada comments
Contact Address 200 YORKLAND BLVD, SUITE 500
NORTH YORK, ONTARIO
CANADA M2J 5C1
Company contact information 1-800-263-4057

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-01-10 French Compare
v12 2019-01-10 English Compare
v11 2018-07-16 French Compare
v10 2018-07-16 English Compare
v9 2018-03-15 French Compare
v8 2018-03-15 English Compare
v7 2018-01-09 French Compare
v6 2018-01-09 English Compare
v5 2017-10-06 English Compare
v4 2017-10-06 English Compare
v3 2017-03-13 French Compare
v2 2017-03-13 English Compare
v1 2017-03-13 English Compare